Decrease in anti-LeishmaniaIgG3 and IgG1 after cutaneous leishmaniasis lesion healing is correlated with the time of clinical cure-Reference-Cited by-同舟云学术

Decrease in anti-LeishmaniaIgG3 and IgG1 after cutaneous leishmaniasis lesion healing is correlated with the time of clinical cure

Published:2012-09-11 Issue:10 Volume:34 Page:486-491
ISSN:0141-9838
Container-title:Parasite Immunology
language:en
Short-container-title:

Author:

FAGUNDES-SILVA G. A.,VIEIRA-GONCALVES R.,NEPOMUCENO M. P.,De SOUZA M. A.,FAVORETO S.,OLIVEIRA-NETO M. P.,DA-CRUZ A. M.,GOMES-SILVA A.

Publisher

Wiley

Subject

Immunology,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3024.2012.01379.x/fullpdf

Reference23 articles.

1. WHO Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 2010

2. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure;Schubach;Am J Trop Med Hyg,1998

3. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?;Mendonça;J Infect Dis,2004

4. Signs of an in situ inflammatory reaction in scars of human American tegumentary leishmaniasis;Morgado;Parasite Immunol,2010

5. Treatment of American cutaneous leishmaniasis: a comparison between low dose (5mg/kg/day) and high dosage (20mg/kg/day) antimony regimens;Oliveira-Neto;Pathol Biol,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and parasitological features of Leishmania infection among gold miners in the Oiapoque basin, an international Brazil-French Guiana border;PLOS Neglected Tropical Diseases;2024-06-26

2. Assessment of pan-Leishmania detection by recombinase polymerase amplification assay;Diagnostic Microbiology and Infectious Disease;2023-02

3. Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins;Emerging Microbes & Infections;2022-09-21

4. Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis;Microbial Pathogenesis;2022-06

5. Validation of an In-House ELISA Method in the Diagnosis of Cutaneous Leishmaniasis Caused by Leishmania donovani in Hambantota District, Sri Lanka;Microorganisms;2022-04-27